Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...
It could be a real game-changer for managing pain. Researchers at UW Medicine say a new pain relief drug was just approved by ...
The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi ® (risdiplam) tablet for people living with spinal muscular atrophy ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...